By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Metabasis Therapeutics, Inc. 

11119 North Torrey Pines Road

La Jolla  California  92037  U.S.A.
Phone: 858-587-2770 Fax: 858-458-3504


SEARCH JOBS


Industry
Biotechnology


Collaborations

Merck & Co., Inc.  – Hepatitis C, Diabetes / Hyperlipidemia

Valeant Pharmaceuticals International  – Hepatitis B





Company News
Ligand Pharmaceuticals Inc. (LGND) Completes Acquisition of Metabasis Therapeutics, Inc. (MBRX) 1/28/2010 8:29:02 AM
Ligand Pharmaceuticals Inc. (LGND) to Acquire Metabasis Therapeutics, Inc. (MBRX) for Cash and Contingent Value Rights 10/27/2009 6:40:48 AM
Metabasis Therapeutics, Inc. (MBRX) Receives Notice of Noncompliance with Nasdaq Listing Requirements 9/21/2009 10:46:18 AM
Metabasis Therapeutics, Inc. (MBRX) Receives Notice of Delisting from Nasdaq Capital Market 9/10/2009 10:22:11 AM
Metabasis Therapeutics, Inc. (MBRX) Hires Financial Advisor to Evaluate Strategic Alternatives 9/3/2009 9:58:18 AM
Metabasis Therapeutics, Inc. (MBRX) Announces the Resignation of Mark Erion, Ph.D., President, CEO & CSO 9/1/2009 7:04:47 AM
Metabasis Therapeutics, Inc. (MBRX)'s Massive Inventory Of Premium Lab & Analytical Equipment Now Available, EquipNet, Inc. Announces 8/13/2009 10:43:15 AM
Metabasis Therapeutics, Inc. (MBRX) Announces Second Quarter 2009 Financial Results 8/7/2009 8:37:30 AM
Metabasis Therapeutics, Inc. (MBRX) Announces Conference Call and Live Webcast to Discuss Second Quarter 2009 Financial Results 7/30/2009 9:30:33 AM
Metabasis Therapeutics, Inc. (MBRX) Announces Merck & Co., Inc. (MRK) Has Selected a Lead AMPK Activator for Late Preclinical Development; Triggers $6 Million Payment to Metabasis 6/11/2009 7:58:53 AM
12345678910...
//-->